Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality

American Journal of Epidemiology

Volumn 179, Issue 6, 2014, Pages 710-720

  Bell, Griffith A ^a   Kantor, Elizabeth D ^a   Lampe, Johanna W ^a   Kristal, Alan R ^a   Heckbert, Susan R ^a   White, Emily ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

cancer; cohort studies; dietary supplements; fish oil; mortality; 3 fatty acids

Indexed keywords

ACETYLSALICYLIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

CANCER; COHORT ANALYSIS; DIET; EPIDEMIOLOGY; EXPERIMENTAL STUDY; FATTY ACID; HEALTH CARE; HEALTH RISK; HEALTH SURVEY; MORTALITY;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; FEMALE; HUMAN; LIFESTYLE; MALE; MORTALITY; RISK FACTOR; UNITED STATES; VITAMIN SUPPLEMENTATION; YOUNG ADULT;

CANCER; COHORT STUDIES; DIETARY SUPPLEMENTS; FISH OIL; MORTALITY; Ω-3 FATTY ACIDS;

AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DIET; DIETARY SUPPLEMENTS; EXERCISE; FATTY ACIDS, OMEGA-3; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; SOCIOECONOMIC FACTORS;

EID: 84895859245     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt326     Document Type: Article

References (39)

1. Bang HO, Dyerberg J, Nielsen AB.Plasma lipid and lipoprotein pattern in GreenlandicWest-coast Eskimos.Lancet.1971;1(7710):1143-1145.
2. Eisenberg DM, Davis RB, Ettner SL, et al.Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.JAMA.1998;280(18):1569-1575.
3. Wang S, Liu Z, Wang L, et al.NF-κB signaling pathway, inflammation and colorectal cancer.Cell Mol Immunol.2009; 6(5):327-334.
4. Li Q, Withoff S, Verma IM.Inflammation-associated cancer: NF-κB is the lynchpin.Trends Immunol.2005;26(6):318-325.
5. Andreeva VA, Touvier M, Kesse-Guyot E, et al.B vitamin and/or ω-3 fatty acid supplementation and cancer: ancillary findings from the Supplementation With Folate, Vitamins B6 and B12, and/or Omega-3 Fatty Acids (SU.FOL.OM3) randomized trial.Arch Intern Med.2012;172(7):540-547.
6. Hooper L, Thompson RL, Harrison RA, et al.Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review.BMJ.2006;332(7544): 752-760.
7. Kwak SM, Myung SK, Lee YJ, et al.Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.Arch Intern Med.2012;172(9):686-694.
8. Mozaffarian D, Wu JHY.Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.J Am Coll Cardiol.2011;58(20): 2047-2067.
9. MacLean CH, Newberry SJ, Mojica WA, et al.Effects of omega-3 fatty acids on cancer risk: a systematic review.JAMA.2006;295(4):403-415.
10. Folsom AR, Demissie Z.Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women.Am J Epidemiol.2004;160(10):1005- 1010.
11. Pocobelli G, Kristal AR, Patterson RE, et al.Total mortality risk in relation to use of less-common dietary supplements.Am J Clin Nutr.2010;91(6):1791-1800.
12. White E, Patterson RE, Kristal AR, et al.VITamins And Lifestyle cohort study: study design and characteristics of supplement users.Am J Epidemiol.2004;159(1):83-93.
13. Patterson RE, Kristal AR, Tinker LF, et al.Measurement characteristics of theWomen's Health Initiative food frequency questionnaire.Ann Epidemiol.1999;9(3):178-187.
14. Schakel SF, Sievert YA, Buzzard IM.Sources of data for developing and maintaining a nutrient database.J Am Diet Assoc.1988;88(10):1268-1271.
15. Satia-Abouta J, Patterson RE, King IB, et al.Reliability and validity of self-report of vitamin and mineral supplement use in the Vitamins and Lifestyle Study.Am J Epidemiol.2003; 157(10):944-954.
16. Calder PC.n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases.Am J Clin Nutr.2006;83(6 suppl): 1505S-1519S.
17. Pocobelli G, Peters U, Kristal AR, et al.Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality.Am J Epidemiol.2009;170(4):472-483.
18. Hu FB, Manson JE.Omega-3 fatty acids and secondary prevention of cardiovascular disease-is it just a fish tale? Comment on "Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease." Arch Intern Med.2012;172(9):694-696.
19. Rizos EC, Ntzani EE, Bika E, et al.Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.JAMA.2012;308(10):1024-1033.
20. Yokoyama M, Origasa H, Matsuzaki M, et al.Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.Lancet.2007; 369(9567):1090-1098.
21. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.Lancet.1999;354(9177):447-455.
22. Kromhout D, Giltay EJ, Geleijnse JM.n-3 fatty acids and cardiovascular events after myocardial infarction.N Engl J Med.2010;363(21):2015-2026.
23. Galan P, Kesse-Guyot E, Czernichow S, et al.Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.BMJ.2010;341:c6273.
24. Rauch B, Schiele R, Schneider S, et al.OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.Circulation.2010;122(21): 2152-2159.
25. Mozaffarian D, Lemaitre RN, King IB, et al.Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.Ann Intern Med.2013;158(7):515-525.
26. Virtanen JK, Mozaffarian D, Chiuve SE, et al.Fish consumption and risk of major chronic disease in men.Am J Clin Nutr.2008;88(6):1618-1625.
27. Geelen A, Schouten JM, Kamphuis C, et al.Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies.Am J Epidemiol.2007;166(10): 1116-1125.
28. Wu S, Feng B, Li K, et al.Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis.Am J Med.2012;125(6):551-559, 559.e1-559.e5.
29. Gerber M.Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies.Br J Nutr.2012; 107(suppl 2):S228-S239.
30. Sczaniecka AK, Brasky TM, Lampe JW, et al.Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort.Nutr Cancer.2012;64(8):1131-1142.
31. Larsson SC, Kumlin M, Ingelman-Sundberg M, et al.Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms.Am J Clin Nutr.2004;79(6): 935-945.
32. Wall R, Ross RP, Fitzgerald GF, et al.Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids.Nutr Rev.2010;68(5):280-289.
33. Kantor ED, Lampe JW, Vaughan TL, et al.Association between use of specialty dietary supplements and C-reactive protein concentrations.Am J Epidemiol.2012;176(11): 1002-1013.
34. Micallef MA, Garg ML.Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals.Atherosclerosis.2009;204(2):476-482.
35. Ebrahimi M, Ghayour-Mobarhan M, Rezaiean S, et al.Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity.Acta Cardiol.2009;64(3):321-327.
36. Overby NC, Serra-Majem L, Andersen LF.Dietary assessment methods on n-3 fatty acid intake: a systematic review.Br J Nutr.2009;102(suppl 1):S56-S63.
37. Freedman LS, Schatzkin A, Midthune D, et al.Dealing with dietary measurement error in nutritional cohort studies.J Natl Cancer Inst.2011;103(14):1086-1092.
38. Weinberg CR, Umbach DM, Greenland S.When will nondifferential misclassification of an exposure preserve the direction of a trend? Am J Epidemiol.1994;140(6): 565-571.
39. Manson JE, Bassuk SS, Lee IM, et al.The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.Contemp Clin Trials.2012;33(1): 159-171.